Company Profile
Eledon Pharmaceuticals, Inc. Stock Price, News & Analysis
- Ticker:
- ELDN
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
3.57 USD (-0.28%)
Close
Last updated: July 27, 2026
272M USD
Market cap
Why the stock is moving
As of Jul 27, 2026, ELDN closed down 0.28% at $3.57. No new same-company headline was identified in the current news window.
Company overview
Business overview
Eledon Pharmaceuticals is a biotechnology company focused on immunology and transplant-related therapies. Its story is built around using immune modulation to improve outcomes in transplant and autoimmune settings.
Geographic Base and Sector Classification
Eledon is headquartered in the United States and listed on NASDAQ. It sits in small-cap immunology biotechnology.
Business Model Characteristics
The company depends on clinical validation, translational confidence, and the ability to keep a focused pipeline funded. Investors usually watch readouts and strategic developments.
Position Within the Biotechnology Landscape
Eledon occupies a niche transplant-immunology position within biotech. The stock is catalyst-sensitive because the company is still proving whether its immune strategy can matter clinically.
Future catalysts
Eledon’s catalysts are tegoprubart and the immunology / transplant pipeline, where the next update can materially move the stock. The company still needs stronger human proof.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer
KYMR · Source: Kymera
- 02
- 03
- 04
- 05
Avalo Therapeutics to Participate in the BTIG Biotechnology Conference
AVTX · Source: Avalo Therapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Eledon Pharmaceuticals, Inc. (ELDN)?
Eledon Pharmaceuticals, Inc. (ELDN) most recently closed at 3.57 USD, a -0.28% move versus the previous session.
What is the market cap of Eledon Pharmaceuticals, Inc. (ELDN)?
Eledon Pharmaceuticals, Inc. currently has a market capitalization of 272M USD on BioPharmSignal.
What does Eledon Pharmaceuticals, Inc. do?
Eledon Pharmaceuticals is a biotechnology company focused on immunology and transplant-related therapies. Its story is built around using immune modulation to improve outcomes in transplant and autoimmune settings.
On which exchange is ELDN stock listed?
Eledon Pharmaceuticals, Inc. (ELDN) is associated with NASDAQ, United States, Biopharma.
What is Eledon?
Eledon’s catalysts are tegoprubart and the immunology / transplant pipeline, where the next update can materially move the stock.
Which conditions is Eledon Pharmaceuticals, Inc. targeting with Eledon?
Eledon Pharmaceuticals, Inc. is associated with immunology based on its company overview and current catalyst commentary.
How does Eledon Pharmaceuticals, Inc. describe recent progress with Eledon?
Eledon’s catalysts are tegoprubart and the immunology / transplant pipeline, where the next update can materially move the stock.
What is Pharmaceuticals?
Eledon Pharmaceuticals is a biotechnology company focused on immunology and transplant-related therapies.